ABL: (2R,3R,4R,5R)-4,5-dihydroxy-2-(hydroxymethyl)-6-oxopiperidin-3-yl beta-D-glucopyranoside
ABL is a Ligand Of Interest in 4QI5 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4QI5_ABL_A_902 | 57% | 35% | 0.13 | 0.905 | 1.51 | 1.05 | 2 | 2 | 0 | 0 | 100% | 1 |
1NAA_ABL_B_1901 | 85% | 40% | 0.101 | 0.968 | 1.01 | 1.32 | 2 | 4 | 0 | 0 | 100% | 1 |
3RJA_ABL_A_604 | 54% | 43% | 0.131 | 0.895 | 1.26 | 0.94 | 2 | 1 | 2 | 0 | 100% | 1 |
2AXR_ABL_A_505 | 48% | 45% | 0.159 | 0.902 | 1.05 | 1.09 | 1 | 1 | 1 | 0 | 100% | 1 |